ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/17 | 2,382 | 2,382 | 2,354 | 2,355 | -24 | -1% | 86,100 |
2023/04/14 | 2,360 | 2,383 | 2,358 | 2,379 | +32 | +1.4% | 68,500 |
2023/04/13 | 2,323 | 2,353 | 2,318 | 2,347 | +31 | +1.3% | 62,800 |
2023/04/12 | 2,315 | 2,338 | 2,312 | 2,316 | +16 | +0.7% | 54,200 |
2023/04/11 | 2,279 | 2,302 | 2,273 | 2,300 | +27 | +1.2% | 75,300 |
2023/04/10 | 2,270 | 2,278 | 2,257 | 2,273 | +23 | +1% | 35,400 |
2023/04/07 | 2,260 | 2,269 | 2,242 | 2,250 | -5 | -0.2% | 42,600 |
2023/04/06 | 2,218 | 2,260 | 2,218 | 2,255 | +12 | +0.5% | 67,700 |
2023/04/05 | 2,253 | 2,271 | 2,235 | 2,243 | -34 | -1.5% | 65,700 |
2023/04/04 | 2,247 | 2,280 | 2,237 | 2,277 | +29 | +1.3% | 67,600 |
2023/04/03 | 2,259 | 2,267 | 2,233 | 2,248 | +3 | +0.1% | 59,100 |
2023/03/31 | 2,230 | 2,249 | 2,230 | 2,245 | +25 | +1.1% | 57,300 |
2023/03/30 | 2,226 | 2,238 | 2,212 | 2,220 | -28 | -1.2% | 60,200 |
2023/03/29 | 2,232 | 2,250 | 2,211 | 2,248 | +33 | +1.5% | 141,100 |
2023/03/28 | 2,224 | 2,224 | 2,201 | 2,215 | +14 | +0.6% | 58,300 |
2023/03/27 | 2,198 | 2,209 | 2,189 | 2,201 | +28 | +1.3% | 65,800 |
2023/03/24 | 2,152 | 2,180 | 2,141 | 2,173 | +20 | +0.9% | 67,300 |
2023/03/23 | 2,154 | 2,182 | 2,144 | 2,153 | -28 | -1.3% | 45,500 |
2023/03/22 | 2,143 | 2,187 | 2,129 | 2,181 | +88 | +4.2% | 103,200 |
2023/03/20 | 2,111 | 2,123 | 2,091 | 2,093 | -35 | -1.6% | 59,000 |
2023/03/17 | 2,150 | 2,169 | 2,125 | 2,128 | -13 | -0.6% | 74,300 |
2023/03/16 | 2,132 | 2,144 | 2,117 | 2,141 | -30 | -1.4% | 62,700 |
2023/03/15 | 2,174 | 2,183 | 2,154 | 2,171 | +18 | +0.8% | 43,000 |
2023/03/14 | 2,175 | 2,175 | 2,130 | 2,153 | -52 | -2.4% | 64,400 |
2023/03/13 | 2,222 | 2,229 | 2,193 | 2,205 | -28 | -1.3% | 58,300 |
2023/03/10 | 2,212 | 2,241 | 2,212 | 2,233 | -9 | -0.4% | 66,000 |
2023/03/09 | 2,213 | 2,242 | 2,213 | 2,242 | +26 | +1.2% | 47,100 |
2023/03/08 | 2,207 | 2,227 | 2,207 | 2,216 | -3 | -0.1% | 43,500 |
2023/03/07 | 2,208 | 2,227 | 2,202 | 2,219 | +26 | +1.2% | 57,000 |
2023/03/06 | 2,213 | 2,214 | 2,190 | 2,193 | -18 | -0.8% | 50,000 |
2023/03/03 | 2,189 | 2,218 | 2,189 | 2,211 | +28 | +1.3% | 68,600 |
2023/03/02 | 2,178 | 2,196 | 2,172 | 2,183 | +5 | +0.2% | 45,800 |
2023/03/01 | 2,183 | 2,194 | 2,176 | 2,178 | -14 | -0.6% | 39,200 |
2023/02/28 | 2,179 | 2,209 | 2,178 | 2,192 | +14 | +0.6% | 112,300 |
2023/02/27 | 2,165 | 2,179 | 2,165 | 2,178 | +4 | +0.2% | 24,300 |
2023/02/24 | 2,169 | 2,178 | 2,153 | 2,174 | +13 | +0.6% | 44,000 |
2023/02/22 | 2,178 | 2,191 | 2,157 | 2,161 | -45 | -2% | 50,600 |
2023/02/21 | 2,197 | 2,209 | 2,192 | 2,206 | +9 | +0.4% | 41,400 |
2023/02/20 | 2,200 | 2,217 | 2,193 | 2,197 | +14 | +0.6% | 45,800 |
2023/02/17 | 2,148 | 2,190 | 2,143 | 2,183 | +25 | +1.2% | 67,000 |
2023/02/16 | 2,175 | 2,177 | 2,150 | 2,158 | -8 | -0.4% | 44,400 |
2023/02/15 | 2,192 | 2,192 | 2,155 | 2,166 | -19 | -0.9% | 57,500 |
2023/02/14 | 2,173 | 2,187 | 2,165 | 2,185 | +33 | +1.5% | 68,600 |
2023/02/13 | 2,160 | 2,165 | 2,145 | 2,152 | -5 | -0.2% | 50,100 |
2023/02/10 | 2,120 | 2,164 | 2,120 | 2,157 | +38 | +1.8% | 108,000 |
2023/02/09 | 2,123 | 2,139 | 2,117 | 2,119 | -5 | -0.2% | 68,400 |
2023/02/08 | 2,123 | 2,138 | 2,122 | 2,124 | +11 | +0.5% | 61,900 |
2023/02/07 | 2,116 | 2,130 | 2,104 | 2,113 | +2 | +0.1% | 84,900 |
2023/02/06 | 2,132 | 2,132 | 2,103 | 2,111 | +29 | +1.4% | 135,200 |
2023/02/03 | 2,072 | 2,098 | 2,050 | 2,082 | -122 | -5.5% | 429,000 |
501~
550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム